Fifth Third Bancorp
SCLN

Fifth Third Bancorp’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Fifth Third Bancorp’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,500
Closed -$17K – 2987
2015
Q3 		$17K Sell
2,500
-500
-17% -$4.28K ﹤0.01% 1812
2015
Q2 		$29K Buy
+3,000
New +$27.3K ﹤0.01% 1657
2013
Q4 		– Sell
-1,000
Closed -$5K – 2289
2013
Q3 		$5K Buy
+1,000
New +$5.57K ﹤0.01% 2037

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fifth Third Bancorp's SCLN Position: Q4 2015 in Review

Fifth Third Bancorp sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2015, closing a stake of 2,500 shares — an estimated $17K sold.

Fifth Third Bancorp first reported a position in SCLN in Q3 2013 and held it in 3 quarters. The position peaked at $29K in Q2 2015. 133 funds tracked by Wall St. Rank hold SCLN as of Q4 2015.

  • Fifth Third Bancorp reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Fifth Third Bancorp sold 2,500 Sciclone Pharmaceuticals Inc shares in Q4 2015, an estimated $17K.
  • Fifth Third Bancorp first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 3 quarters.
  • Fifth Third Bancorp's Sciclone Pharmaceuticals Inc position peaked at $29K in Q2 2015.
  • 133 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2015.

Based on Fifth Third Bancorp's 13F filing for Q4 2015, filed 16 Feb 2016.